Resilience-Building Program for Young Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help young cancer survivors and their families manage stress and build resilience after facing serious illness. Participants will use the PRISM program, a mobile app with six sessions focused on stress management skills. The study will compare three groups—app-only, video coach, and text coach—to determine the best method for fostering resilience. Young people aged 12 to 25 who have completed their main cancer treatment and can speak and read English or Spanish might be a good fit for this trial. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance support for young cancer survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the PRISM Program is safe for young cancer survivors?
Research shows that the PRISM program helps people manage stress and build resilience. It teaches skills such as handling stress, setting goals, and thinking positively. Studies have found the program to be safe. Participants in earlier research did not experience unexpected distress. The program ensures participants feel supported and not overwhelmed. Overall, PRISM aims to prepare people to handle stress effectively without causing harm.12345
Why are researchers excited about this trial?
Researchers are excited about the PRISM Program for young cancer survivors because it offers a fresh approach to building resilience. Unlike traditional psychosocial support, which often involves in-person therapy or counseling, the PRISM Program leverages digital platforms, including a mobile app and video or text coaching, making it more accessible and flexible for young survivors. This program is designed to be self-guided and interactive, encouraging participants to engage with the material at their own pace. By re-randomizing participants, the program can also adapt to individual needs, potentially offering more personalized support options. This innovative approach aims to empower young survivors with tools to manage stress and improve their overall well-being, which is why researchers are keen to explore its effectiveness.
What evidence suggests that the PRISM Program is effective for building resilience in young cancer survivors?
Research shows that the PRISM program, available in various formats to trial participants, helps young people with serious illnesses become more resilient and feel less psychological distress. One study found that after three months, participants experienced a noticeable increase in resilience and hope. Specifically, their resilience scores increased by an average of 1.3 points, while those not using PRISM saw a decrease. The program teaches stress management skills, which can greatly improve daily life. Overall, studies support PRISM as a valuable tool for building resilience and enhancing well-being among young cancer survivors.26789
Who Is on the Research Team?
Abby Rosenberg, MD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for young individuals aged 12 to 25 who are dealing with anxiety or stress due to a serious illness. They must be able to speak and read English or Spanish, and be cognitively capable of participating in sessions and completing surveys as judged by the investigator.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the PRISM program through app, text, or video sessions, including baseline and 3-month questionnaires
Re-randomization and Continued Treatment
Participants may be re-randomized to different groups or referred to psychosocial support, continuing PRISM sessions until the final survey
Follow-up
Participants are monitored for resilience and quality of life outcomes after completing the PRISM program
What Are the Treatments Tested in This Trial?
Interventions
- PRISM Program
PRISM Program is already approved in United States for the following indications:
- Psychosocial support for adolescents and young adults with cancer
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
National Cancer Institute (NCI)
Collaborator